10.2% swing bad news for Arch Resources Inc. (ARCH:NYQ) stocks

0Comments

Arch Resources Inc. (ARCH:NYQ) saw one of the biggest daily changes on Wall Street, down 10.2 percent throughout the day.

It fell $16.66, placing it 49th among the top 50 biggest swings in Wall Street during the time frame.

Shares in Arch Resources Inc. finished on Aug. 30 at $147.27.

Arch Resources Inc. employs 3,300 people and has reported $995,180,000 USD in income.

Stock fluctuations are affected by several factors, from news about the company involved to global trade difficulties or successes.

Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.

Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”

Nothing in this article is to be assumed as financial advice.

Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.

Top 50 biggest stock market swings on Aug. 30

Company Name Percentage Change Current Trading Price
ACS Global Inc. 111% $5
Glassbridge Enterprises Inc. 53.3% $69
American Metals Recovery and Recycling Inc. 47.8% $2.66
IN8BIO, Inc. 39.4% $2.76
Fortium Holdings Corp. -31.5% $1.11
Liquidia Corp. -30.4% $5.38
Giga-tronics Inc. -29.1% $1.05
Kinetic Group Inc. -28% $3.53
4 Less Group Inc. 24.1% $5
Video Display Corp. 21.3% $1.82
Rapid Therapeutic Science Laboratories Inc. -20.5% $1.75
TraqIQ Inc. -20% $2.4
Advaxis Inc. -19.5% $3.18
Green Planet Bio Engineering Co. Ltd. -18.6% $2.1
American Outdoor Brands Inc. 17.1% $9.1
Jounce Therapeutics Inc. -15.9% $3.61
Augmedix Inc. 15.6% $1.85
Hour Loop Inc. 15.2% $3.78
Astronics Corp. -15% $8.92
Faraday Future Intelligent Electric Inc. -15% $1.19
Houston American Energy Corp. -14.7% $4.23
Allovir Inc. -14.7% $6.26
Enservco Corp. -14.7% $1.68
Bellerophon Therapeutics Inc. -14.5% $1.24
Inhibikase Therapeutics Inc. 14.5% $1.01
Intellicheck Inc. 13.5% $3.36
Bioxytran Inc. 12.9% $1.05
Intercept Pharmaceuticals Inc. -12.4% $16.28
Avid Technology Inc. 12.1% $27.04
Clarus Corp. -12% $16.52
Lzg International Inc. 12% $2.8
Aquestive Therapeutics Inc. 11.8% $1.52
Optimus Healthcare Services Inc. -11.8% $1.5
Big Lots Inc. 11.7% $24.08
Power Solutions International Inc. 11.7% $2.01
Lightwave Logic Inc. -11.5% $8.58
Spanish Broadcasting System Inc. -11.4% $1.4
Liberty Tripadvisor Holdings Inc. -11.2% $35.02
8×8 Inc. 11.2% $5.27
Immunovant Inc. -11.1% $5.18
Lindblad Expeditions Holdings Inc. -10.8% $7.85
Adaptive Biotechnologies Corp. -10.7% $8.65
Intrepid Potash Inc. -10.6% $47.76
Kura Sushi USA Inc. -10.6% $74.26
American Woodmark Corp. 10.5% $52.44
Town Center Bank -10.5% $3.4
Monte Rosa Therapeutics Inc. -10.3% $7.91
Athersys Inc. -10.3% $2.78
Arch Resources Inc. -10.2% $147.27
New Concept Energy Inc. -10% $1.53


Related

Peter Mihalick, Public Policy VP for AMIA

Public Policy VP Mihalick scrutinizes 340B program for ‘shortchanging patients to increase profits,’ as 340B concerns grow in Missouri

Peter Mihalick of the American Medical Informatics Association warned that the 340B Drug Pricing Program may incentivize nonprofit hospitals to prioritize profits over patient savings, as scrutiny over the program continues to grow.

Laura V. Swett, Chairman of Federal Energy Regulatory Commission (FERC)

Regular gas at $2.68 per gallon in St. Louis city in week ending Mar. 14

The cheapest per-gallon price for regular gas in St. Louis city during the week ending Mar. 14 was $2.68 per gallon.

Roger Harris, president, Amtrak, left, and Sean Duffy, U.S. Transportation Secretary

Texas Eagle route serving St. Louis part of Amtrak’s record ridership year

Amtrak’s Texas Eagle service through St. Louis contributed to a record-breaking fiscal year for the national passenger railroad, which reported its highest ridership totals in company history.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from St. Louis Reporter.